We are seeing our community pharmacies across the country disappear.

Addressing these fees would not only refocus an important part of our drug supply chain to improve patient health, but combat the financial uncertainty that these small businesses face.

Need to have certainty that whatever they are selling they know what it costs them themselves.

I think we can all agree that without prices that make these lifesaving drugs accessible, innovation for the sake of innovation is not why we were sent to Congress.

The Fair Pricing Act seeks to reduce prescription drug costs by--for seniors by bringing all negotiated price concessions at the point of sale.

I commend you all for your bipartisan consideration and the passage of H.R. 2296, the More Efficient Tools to Realize Information for Consumers Act.

These unpredictable fees increase patient cost sharing for drugs, pushing them into coverage gaps.

A recent PwC report estimated that by 2030, AI and machine-learning technologies could increase North American GDP by $3.7 trillion and could increase global GDP by $15.7 trillion.